Cervomed Stock Today
| CRVO Stock | 2.17 0.07 3.13% |
PerformanceVery Weak
| Odds Of DistressVery High
|
CervoMed is selling at 2.17 as of the 26th of February 2025; that is 3.13% down since the beginning of the trading day. The stock's open price was 2.24. CervoMed has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.
Moving against CervoMed Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
CervoMed Stock Highlights
| CEO, CoFounder | John MD |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength | |
CervoMed (CRVO) is traded on NASDAQ Exchange in USA. It is located in 20 Park Plaza, Boston, MA, United States, 02116 and employs 8 people. CervoMed is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.49 M. CervoMed conducts business under Biotechnology sector and is part of Health Care industry. The entity has 8.25 M outstanding shares of which 1.04 M shares are currently shorted by private and institutional investors with about 6.08 trading days to cover.
CervoMed generates negative cash flow from operations
Check CervoMed Probability Of Bankruptcy
Ownership AllocationThe market capitalization of CervoMed is USD18.49 Million. CervoMed retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check CervoMed Ownership Details
CervoMed Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. CervoMed market risk premium is the additional return an investor will receive from holding CervoMed long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (1.34) | |||
| Total Risk Alpha | (1.42) | |||
| Treynor Ratio | (1.47) |
CervoMed Stock Against Markets
CervoMed Corporate Management
| Mark Rosch | SVP Management | Profile | |
| Claudia MD | Senior Science | Profile | |
| John Tanner | Chief Officer | Profile | |
| William JD | General Secretary | Profile | |
| Kelly MHA | Senior Development | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CervoMed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CervoMed. If investors know CervoMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CervoMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CervoMed is measured differently than its book value, which is the value of CervoMed that is recorded on the company's balance sheet. Investors also form their own opinion of CervoMed's value that differs from its market value or its book value, called intrinsic value, which is CervoMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CervoMed's market value can be influenced by many factors that don't directly affect CervoMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CervoMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if CervoMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CervoMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.